Shares to ride out vaccine scare
By Shi Jing in Shanghai | China Daily | Updated: 2018-07-30 07:41
Equities take a beating after drug scandal probe begins, but analysts optimistic
Experts said they maintain their positive outlook on the long-term performance of the A-share medical sector, despite the sector slumping immediately on the first trading day following a vaccine scandal in China that went viral online over the weekend of July 21 and 22.
A widely viewed and circulated online post accused Changchun Changsheng Bio-tech Co of fabricating production and inspection data on a freeze-dried rabies vaccine designed for human use. The company was also alleged to have manufactured and sold inferior-quality vaccines for infants a few months ago.
Photo